Morepen Laboratories Limited’s (NSEI:MOREPENLAB) most recent return on equity was a substandard 7.56% relative to its industry performance of 13.67% over the past year. An investor may attribute an ...

Morepen Laboratories Limited (NSEI:MOREPENLAB) is a small-cap stock with a market capitalization of ₹18.76B. While investors primarily focus on the growth potential and competitive landscape of the ...

Get all latest & breaking news on Morepen Laboratories. Watch videos, top stories and articles on Morepen Laboratories at moneycontrol.com.

Here's an analysis of the annual report of MOREPEN LABS for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of MOREPEN LABS. Also includes updates on the valuation ...

https://www.india.com/news/agencies/morepen-labs-reports-24-pct-jump-in-its-q2-net-profit-backed-by-lower-interest-cost-and-improved-home-diagnostics-sales-2623477 ...

With today's rally, the pharma stock has now rallied 156 percent from its 52-week low of ₹31.31, hit on October 26, 2024. The stock has jumped 85 percent in the last 1 year and over 61 percent in 2024 ...

Aaaaaaaa Aaaaa 1,643.5 +18.24% 1,943.3 A A Aaaaaaa A A 5,300.0 +15.76% 6,135.3 ...

New Delhi [India], Nov 9 (ANI-NewsVoir): Morepen Laboratories Ltd. entered into a tie up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000 crore probiotic market ...

Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) and pharma player Morepen Laboratories on Tuesday announced the production of the first test batch of Russian Covid-19 vaccine ...